Endeavour Silver (EXK)
(Real Time Quote from BATS)
$4.09 USD
+0.07 (1.74%)
Updated Sep 25, 2024 01:26 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
EXK 4.09 +0.07(1.74%)
Will EXK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EXK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EXK
Endeavour Silver (EXK) Restarts Guanacevi Mill at Reduced Rate
Buenaventura (BVN) Reports Q2 Production & Sales Volume
EXK: What are Zacks experts saying now?
Zacks Private Portfolio Services
First Majestic (AG) Q2 Silver Production Rises Sequentially
Avino Silver (ASM) Q2 Silver Equivalent Output Rises Y/Y
Fortuna Silver (FSM) Q2 Gold Equivalent Production Up 25% Y/Y
Other News for EXK
The Best Silver Miners
Buy Rating Affirmed for Exact Sciences Following Promising CRC Screening Test Data
Buy Rating for Exact Sciences: Promising CRC Screening Test Outperforms with High Accuracy and Market Potential
Buy Rating Affirmed for Exact Sciences on Robust CRC Test Results and Strategic Pipeline Advancements
Commodity Roundup: Gold notches record high on large rate cut bets, oil eyes weekly gain